Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Menogaril × Clear all

Phase

Phase NA 5 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cisplatin 889 Cyclophosphamide 838 Carboplatin 832 Radiotherapy 780 Bevacizumab 732 Gemcitabine 706 pembrolizumab 655 Docetaxel 652 Paclitaxel 642 Oxaliplatin 605 Capecitabine 566 Fluorouracil 506 Rituximab 496 Nivolumab 438 Dexamethasone 430 Etoposide 408 Doxorubicin 397 Irinotecan 388 Drug Therapy 336 Leucovorin 335 Cytarabine 301 Cetuximab 293 Lenalidomide 287 Trastuzumab 280 Pemetrexed 278 durvalumab 261 Filgrastim 249 Magnetic Resonance Spectroscopy 237 Temozolomide 236 Prednisone 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02710422 2019-09-11

MMEP

University of Miami

Phase 2 Terminated

24 enrolled 14 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡